What Metagenomi Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 2 | 2 |
| Sells | 3 | 13 |
| Total trades | 5 | 23 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 20,000 | 565,500 |
| Disposed | 4,409 | 250,927 |
| Net activity | +15,591 | +314,573 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Reid Laurence | Director | Sep 09 | Open-market buy · P | +117 | $1.18 | +$138 | 20,000 |
| Reid Laurence | Director | Sep 09 | Open-market buy · P | +19,883 | $1.17 | +$23.3K | 19,883 |
| Wapnick Pamela | Chief Financial Officer | Sep 08 | Open-market sale · S | −1,911 | $1.16 | −$2.21K | 206,580 |
| Irish Jian | See Remarks | Sep 08 | Open-market sale · S | −2,140 | $1.16 | −$2.48K | 375,393 |
| Wein Matthew | See Remarks | Sep 08 | Open-market sale · S | −358 | $1.16 | −$415 | 126,133 |
| Wein Matthew | See Remarks | Jun 05 | Open-market sale · S | −558 | $1.30 | −$725 | 126,491 |
| Irish Jian | See Remarks | Jun 05 | Open-market sale · S | −3,737 | $1.30 | −$4.85K | 377,533 |
| Wapnick Pamela | Chief Financial Officer | Jun 05 | Open-market sale · S | −2,884 | $1.30 | −$3.75K | 208,491 |
| Wapnick Pamela | Chief Financial Officer | Apr 01 | Grant / award · A | +24,000 | — | — | 211,375 |
| Wein Matthew | See Remarks | Apr 01 | Grant / award · A | +11,000 | — | — | 125,549 |
| Irish Jian | See Remarks | Apr 01 | Grant / award · A | +46,000 | — | — | 379,770 |
| Irish Jian | Chief Executive Officer | Mar 05 | Open-market sale · S | −1,607 | $1.60 | −$2.57K | 333,770 |
| Wapnick Pamela | Chief Financial Officer | Mar 05 | Open-market sale · S | −1,581 | $1.60 | −$2.53K | 187,375 |
| Wein Matthew | See Remarks | Mar 05 | Open-market sale · S | −482 | $1.60 | −$771 | 114,549 |
| Thomas Brian C. | Director | Dec 05 | Open-market sale · S | −3,830 | $1.77 | −$6.79K | 2,510,960 |
| Irish Jian | Chief Executive Officer | Dec 05 | Gift · G | −228,462 | — | — | 335,377 |
| Irish Jian | Chief Executive Officer | Dec 05 | Open-market sale · S | −1,602 | $1.77 | −$2.84K | 563,839 |
| Wapnick Pamela | Chief Financial Officer | Dec 05 | Open-market sale · S | −1,576 | $1.77 | −$2.79K | 188,956 |
| Wein Matthew | See Remarks | Dec 05 | Open-market sale · S | −199 | $1.77 | −$353 | 115,031 |
| Wein Matthew | See Remarks | Dec 01 | Grant / award · A | +96,000 | $1.60 | +$154K | 115,230 |
Loading...